First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.
<h4>Introduction</h4>The WHO urges action against the threat posed by HIV drug resistance. It is well known that the sensitivity of Next-Generation Sequencing (NGS) is greater than that of Sanger Sequencing (SS). The objective of this study was to evaluate the performance of the novel NG...
Main Authors: | Géraldine Dessilly, Léonie Goeminne, Anne-Thérèse Vandenbroucke, François E Dufrasne, Anandi Martin, Benoît Kabamba-Mukadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0209561 |
Similar Items
-
Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.
by: Géraldine Dessilly, et al.
Published: (2019-01-01) -
P2 Clinical evaluation of the next-generation sequencing (NGS) for detection of drug-resistance mutations in HIV-1
by: G. Dessilly, et al.
Published: (2017-09-01) -
Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital
by: Sylvie Goletti, et al.
Published: (2019-08-01) -
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database
by: Delforge Marie-Luce, et al.
Published: (2008-02-01) -
The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium
by: Tinne Lernout, et al.
Published: (2019-05-01)